Related Experiment Video
Updated: Aug 12, 2026
12:03
Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
The history and background of Augmentin
Summary
Beta-lactamase enzymes cause bacterial resistance to antibiotics like penicillin. Clavulanic acid, a beta-lactamase inhibitor, restores antibiotic effectiveness against resistant bacteria.
Area of Science:
- Microbiology
- Pharmacology
- Biochemistry
Background:
- Bacterial resistance to beta-lactam antibiotics is a significant clinical challenge.
- Beta-lactamase enzymes are a primary mechanism of this resistance, inactivating antibiotics.
- Natural compounds offer potential solutions for overcoming antibiotic resistance.
Purpose of the Study:
- To investigate the properties and potential of clavulanic acid as a beta-lactamase inhibitor.
- To assess the efficacy of clavulanic acid in restoring sensitivity to beta-lactam antibiotics.
- To explore the clinical application of clavulanic acid in combination therapy.
Main Methods:
- Isolation and characterization of clavulanic acid from Streptomyces clavuligerus fermentation.
- In vitro testing of clavulanic acid's inhibitory activity against various beta-lactamases.
- Evaluation of clavulanic acid's structural similarity to beta-lactam antibiotics.
- Assessment of oral absorption and clinical efficacy in combination with amoxicillin.
Main Results:
- Clavulanic acid effectively inhibits a broad spectrum of beta-lactamases from diverse bacterial species.
- The compound demonstrates structural resemblance to penicillins and cephalosporins.
- Clavulanic acid is orally bioavailable and shows clinical utility when combined with amoxicillin.
- Resistant organisms become sensitive to antibiotics in the presence of clavulanic acid.
Conclusions:
- Clavulanic acid is a potent, naturally occurring beta-lactamase inhibitor.
- It represents a valuable therapeutic agent for combating bacterial resistance to beta-lactam antibiotics.
- Combination therapy with clavulanic acid enhances the effectiveness of existing antibiotics.
Related Concept Videos
00:57Antibiotic Selection
Overview
01:27Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
01:23Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration
Drug elimination from the body primarily occurs through metabolic and excretion pathways. Hepatic metabolism transforms lipophilic drugs into hydrophilic forms for excretion, typically via enzymatic processes classified as phase I (modification) and phase II (conjugation). Renal excretion eliminates drugs and metabolites through filtration and secretion in the kidneys. Impairment in liver or kidney function can hinder these processes, delaying drug clearance and extending the drug’s half-life.
01:27Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...